Lilyan Wright
Genentech
5 Papers
98 Citations
Lilyan Wright is an academic researcher from Genentech. The author has contributed to research in topics: Inflammatory bowel disease & Calprotectin. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors.
Guy Young,Ri Liesner,Tiffany Chang,Robert F. Sidonio,Johannes Oldenburg,Víctor Jiménez-Yuste,Johnny Mahlangu,Rebecca Kruse-Jarres,Michael Wang,Marianne Uguen,Michelle Y. Doral,Lilyan Wright,Christophe Schmitt,Gallia G. Levy,Midori Shima,Maria Elisa Mancuso +15 more
TL;DR: Emicizumab prophylaxis has been shown to be a highly effective novel medication for children with hemophilia A and inhibitors and two of 88 participants developed antidrug antibodies (ADAs) with neutralizing potential, ie, associated with decreased emicIZumab plasma concentrations.
315
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging
William A. Faubion,Joel G. Fletcher,Sharon O'Byrne,Brian G. Feagan,Willem Js de Villiers,Bruce Salzberg,Scott E. Plevy,Deborah D. Proctor,John F. Valentine,Peter D.R. Higgins,Jeffrey M. Harris,Lauri Diehl,Lilyan Wright,Gaik W. Tew,Diana Luca,Karen Basu,Mary E. Keir +16 more
TL;DR: Incorporation of both ICO and CTE into a single measure increased biomarker performance in CD, and it was found that use of the ICO-CTE increased specificity of known biomarkers.
105
Erratum: EMerging BiomARKers in inflammatory bowel disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for crohn's disease activity: Role of cross-sectional imaging (American Journal of Gastroenterology (2013) 108 (1891-1900) DOI: 10.1038/ajg.2013.354)
William A. Faubion,Joel G. Fletcher,Sharon O'Byrne,Brian G. Feagan,Willem J.S. de Villiers,Bruce Salzberg,Scott E. Plevy,Deborah D. Proctor,John F. Valentine,Peter D.R. Higgins,Jeffrey M. Harris,Lauri Diehl,Lilyan Wright,Gaik W. Tew,Diana Luca,Karen Basu,Mary E. Keir +16 more
3
Patent
Procédés pour le diagnostic et le traitement d'une affection abdominale inflammatoire
Jason A. Hackney,Mary E. Keir,Lilyan Wright +2 more
- 16 May 2014
TL;DR: La presente invention concerne des biomarqueurs pour le diagnostic d'une affection abdominale inflammatoire comprenant la maladie de Crohn avec fibrose ou fibrostenose, et the rectocolite hemorragique ainsi que des procedes d'utilisation desdits biomarquesurs.
Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele.
Steven E. Kauder,Lydia Santell,Elaine Mai,Lilyan Wright,Elizabeth Luis,Elsa N N'Diaye,Jeff Lutman,Navneet Ratti,Susan M. Sa,Henry R. Maun,Eric Stefanich,Lino C. Gonzalez,Robert R. Graham,Lauri Diehl,William A. Faubion,Mary E. Keir,Judy Young,Amitabha Chaudhuri,Robert A. Lazarus,Jackson G. Egen +19 more
TL;DR: Reducing the quantities of circulating MSP, the 689C polymorphism, or a variant in linkage disequilibrium with this polymorphism may impact RON ligand availability and thus receptor activity.